Page 8694
The world’s most exciting festival of ideas and discovery London ExCeL October 10–13 2019.
Jun 16, 2019
New Gene Therapy Priced at $1.8 Million in Europe
Posted by Genevieve Klien in category: biotech/medical
A new gene therapy for a rare blood disorder will sell for €1.6 million ($1.8 million) in Europe, according to the maker of the recently approved treatment, whose sticker price is the latest indication that already high drug costs are continuing to climb.
After it goes on sale, the Zynteglo gene therapy from Bluebird Bio Inc. will be the second-most expensive drug in the world after Novartis’s $2.1 million Zolgensma gene therapy, which was recently approved for sale in the U.S.
Jun 16, 2019
New CRISPR research partners defend academic-industry model
Posted by Genevieve Klien in category: biotech/medical
The collaboration, its architects say, was designed to carefully address questions familiar to partnerships involving academic and industry scientists.
Jun 16, 2019
Chronic Wasting Disease: A Big Problem For Wildlife
Posted by Genevieve Klien in categories: biotech/medical, neuroscience
You may be familiar with bovine spongiform encephalopathy, better known as mad cow disease. Did you know there’s a lesser-known—but similar—illness that affects deer, moose, and elk? It’s called chronic wasting disease, and like mad cow, it is also a brain disease, thought to be caused by a malformed, twisted protein called a prion. CWD leads to unusual behavior, and often results in the animals becoming gruesomely thin before they die. First discovered in 1967, CWD now has been detected in at least 26 states, three Canadian provinces, Norway, Sweden, and South Korea.
Rae Ellen Bichell, a reporter with the Mountain West News Bureau and KUNC, explored chronic wasting disease in a multipart series titled “ Bent Out Of Shape.” She joins Ira to talk about the disease, research into its origin and spread, and what’s known about the possible effects of human exposure to CWD.
Check out the full series.
Jun 16, 2019
The woman who founded $1 billion biotech Gossamer told us about the 3 jobs that prepared her to be a first-time CEO
Posted by Genevieve Klien in categories: biotech/medical, employment
Sheila Gujrathi has worked as a doctor, a McKinsey consultant, and at an up-and-coming biotech. Each role prepared her to be CEO in different ways.
Jun 16, 2019
LulzBot 3D Bioprinting Collaboration Brings New Innovations
Posted by Quinn Sena in categories: 3D printing, bioprinting
New LulzBot bioprinting hardware coming 2019 with long term goal of printing real functional tissues.
Jun 16, 2019
Toward artificial intelligence that learns to write code
Posted by Quinn Sena in category: robotics/AI
Researchers combine deep learning and symbolic reasoning for a more flexible way of teaching computers to program.
Jun 16, 2019
Over-the-air wireless charging will come to smartphones
Posted by Quinn Sena in category: mobile phones
Jun 16, 2019
Ebola vaccine shows ‘very impressive’ performance in outbreak
Posted by Quinn Sena in category: biotech/medical
The experimental Ebola vaccine being used to try to contain the outbreak in the Democratic Republic of the Congo is protective 97.5% of the time.